Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome
Annals of the Rheumatic Diseases · 2026
DOI: 10.1016/j.ard.2025.09.013 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Annals of the Rheumatic Diseases, 2026. Verfasst von Clémence David und 55 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, Paris, France; Department of Internal Medicine, Hôpital Bichat-Claude Bernard, …. Hauptthemen laut MEDLINE: Hereditary Autoinflammatory Diseases, Coatomer Protein. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: European Research Council, Medical Research Council, Fondation pour la Recherche Médicale.
Abstract (Originalsprache)
OBJECTIVES: COPA (coatomer subunit alpha) syndrome is a rare monogenic autoinflammatory disease due to heterozygous mutations in COPA. It has phenotypic overlap with STING (Stimulator of interferon genes)-associated vasculopathy with onset in infancy (SAVI), although the spectrum of clinical manifestations is not yet fully defined. Our aim was to better delineate the clinical phenotype of this rare disorder in a European cohort. METHODS: Methods include assessment of clinical, imaging, and immunological data from 46 individuals (29 families) carrying a COPA mutation. RESULTS: Among the 46 individuals carrying a COPA mutation, 38 had at least 1 clinical manifestation likely related to their mutant state (clinical penetrance of 83%). Twenty-two (58%) symptomatic patients were female, with a median age at disease onset of 3 years (range 0-50 years). Pulmonary involvement was observed in 34 patients, with interstitial lung disease in most cases (n = 31) and diffuse alveolar haemorrhage in 11 individuals. Twenty-six patients demonstrated joint involvement, and 7 had documented kidney disease. Previously undescribed features included skin (n = 12), cardiac (n = 8), gastrointestinal (n = 7), and hepatic involvement (n = 5). All but 1 patient tested positive for autoantibodies, and increased interferon signalling was noted in all those tested. Twenty-two patients were treated with Janus kinase inhibitors with promising efficacy. CONCLUSIONS: We report a large European cohort of patients with COPA syndrome. While confirming the core organ features (lung, joint, and kidney) of the disease, our data expand the phenotype to include cardiac, skin, and gastrointestinal features, further demonstrating the clinical overlap with SAVI and other type I interferonopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, Paris, France; Department of Internal Medicine, Hôpital Bichat-Claude Bernard, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, F…
- Paediatric Pulmonology Department and Reference Centre for Rare Lung Diseases RespiRare, INSERM UMR_S933 Laboratory of Childhood Genetic Diseases, Armand Trousseau Hospital, Sorbonne University and APHP, Paris, France.
- Childhood Arthritis and Rheumatic Diseases Unit, Birmingham Women's and Children's Hospital NHSFT, Birmingham, UK.
- Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.
- Department of Paediatric Haematology-Immunology and Rheumatology, Necker-Enfants Malades Hospital, Assistance Publique - Hôpitaux de Paris (APHP), and Reference Centre for Inflammatory Rheumatism, Autoimmune Diseases an…
- Pneumology Department, Darmstädter Kinderkliniken Prinzessin Margaret, Darmstadt, Germany; Member of the chILD-EU Register Group.
Förderung
- European Research Council
- Medical Research Council
- Fondation pour la Recherche Médicale
Zitieren
APA
David, C., Nathan, N., Al-Abadi, E., Arkwright, P. D., Bader-Meunier, B., Becker, S., Belot, A., Brennan, M., Breton, S., Bondet, V., Cadranel, J., Coulomb l'Hermine, A., De Almeida, S., Duffy, D., Poch, T. C., de Becdelièvre, A., El Khalifi-Boulisfane, S., Gattorno, M., Gispert-Saüch, M., …, & Frémond, M. L. (2026). Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2025.09.013
Vancouver
David C, Nathan N, Al-Abadi E, Arkwright PD, Bader-Meunier B, Becker S, et al. Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome. Annals of the Rheumatic Diseases. 2026. doi:10.1016/j.ard.2025.09.013
BibTeX
@article{David2026,
author = {David, Clémence and Nathan, Nadia and Al-Abadi, Eslam and Arkwright, Peter D and Bader-Meunier, Brigitte and Becker, Sebastian and Belot, Alexandre and Brennan, Mary and Breton, Sylvain and Bondet, Vincent and Cadranel, Jacques and Coulomb l'Hermine, Aurore and De Almeida, Sébastien and Duffy, Darragh and Poch, Teresa Clavaguera and de Becdelièvre, Alix and El Khalifi-Boulisfane, Siham and Gattorno, Marco and Gispert-Saüch, Montse and Gothe, Florian and Hatchuel, Yves and Herdliczko, Daniela and Kilinc, Ayse Ayzit and Koucky, Vaclav and Labouret, Géraldine and Manna, Raffaele and Maillard, Hélène and Matoses Ruipérez, María Luisa and Matucci-Cerinic, Caterina and Mensa-Vilaro, Anna and Michel, Katarzyna and Molina, Thierry Jo and Lopez Montesinos, Berta and Newman, William G and Papenkort, Julia and Rapp, Christina and Rames, Cinthia and Rice, Gillian I and Rose, Markus A and Reumaux, Heloise and Sailler, Laurent and Schwerk, Nicolaus and Seabra, Luis and Sellam, Jérémie and Taddio, Andrea and Thumerelle, Caroline and Tommasini, Alberto and Tusseau, Maud and Volpi, Stefano and Wetzke, Martin and Weiss, Laurence and Welfringer-Morin, Anne and Wislez, Marie and Griese, Matthias and Crow, Yanick J and Frémond, Marie-Louise},
title = {Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome},
journal = {Annals of the Rheumatic Diseases},
year = {2026},
doi = {10.1016/j.ard.2025.09.013}
}
EUVIMED